Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

NCT04224740 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Penile Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Standard of care therapy

Sponsor

Latin American Cooperative Oncology Group

Collaborators

[object Object]